Cell Impact is continuing to develop its business and operations and will maintain the previously communicated sales target for 2024, but given the development of the market and the company, we have set a new sales target to exceed sales of SEK 600 million in 2027. As far as the profitability target is concerned, the EBITDA break-even is expected to be reached in 2025 driven by greatly improved productivity through Cell Impact’s Phase II program and higher sales volumes.
Summary of financial targets:
- Sales target 2024: SEK 250–300 million
- Sales target 2027: >SEK 600 million
- Profitability targets (EBITDA) >15 percent in the medium term